Thus, both PTPN1 and PTPN2 regulate ALK phosphorylation and activity, whilst ALCL patients who had developed resistance to ALK inhibitors demonstrated downregulation of PTPN1/PTPN2 expression. This evidence concerns the gene PTPN2 and anaplastic large cell lymphoma.